Study of thalassemia, sickle cell, and inherited anemia with COVID

This study looks at COVID-19 in people who have (or have had) blood cancers and are positive for SARS‑CoV‑2. It may help doctors understand how COVID-19 affects people with blood cancers and guide care.

This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.

This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.

This study looks at how cancers occur and what they look like in people with certain inherited blood disorders, such as beta-thalassemia, hemoglobin H disease, and sickle cell disease. It may help doctors better understand cancer patterns in these conditions so care can be improved.

This study looks at how your genes can affect inherited blood conditions like sickle cell disease and thalassemia. It may help researchers understand why symptoms differ from person to person, which could guide better future treatments.

This study looks at what makes people with thalassemia or sickle cell anemia more likely to develop liver disease. It aims to find factors that could help prevent or manage liver complications.